THERALLO

Live / Allowed — Publication / registration review complete (as of 24 Mar 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 Oct 2025 filing date already counts against anyone who files later.

Record

Serial number
99472514
Mark type
Stylized text
Filed
31 Oct 2025
Published for opposition
14 Apr 2026
Attorney of record
Pina Campagna

Goods and services

  • Class 005 — Pharmaceuticals: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases; Anti-inflammatories; Pharmaceutical preparations for activating cell function for medical purposes; Biological preparations for the treatment of cancer; Biological preparations for use in cell cultures for medical purposes; Biochemical reagents for medical or veterinary purposes; Biological tissue cultures for medical purposes; Stem cells for medical purposes; Cell culture media for medical purposes
  • Class 042 — Scientific and technological services: Research and development in the field of allogeneic and autologous molecular and cell therapies; Scientific and technological services, namely, research and design in the field of allogeneic and autologous molecular and cell therapies; Medical research services; Pharmaceutical research services; Research and development in the field of stem cells, cell and gene therapy and biotechnology; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing scientific research information in the field of stem cells, cell and gene therapy and biotechnology; Scientific study and research in the field(s) of molecular and allogeneic or autologous cell therapy; Providing medical and scientific research information

Owner

Prosecution history

  • 18 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 16 Mar 2026 — ASSIGNED TO EXAMINER
  • 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 31 Oct 2025 — APPLICATION FILING RECEIPT MAILED
  • 31 Oct 2025 — NEW APPLICATION ENTERED

View this trademark record on Marksy